- A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial
-
Hori K, Nishio S, Ushijima K, Kasamatsu Y, Kondo E, Takehara K, Ito K
- KMID: 2526119
- J Gynecol Oncol.
- 2021 Jul;32(4):e64.
- doi: 10.3802/jgo.2021.32.e64
Objective To determine the safety and efficacy of dose-dense (dd) paclitaxel (PTX) and carboplatin (CBDCA) in treating advanced or recurrent endometrial cancer. Methods Women aged 20–75 years with histologically confirmed endometrial cancer, the... -
- CITED
-
- Close
- SHARE
-
- Close
